FIELD: chemistry.
SUBSTANCE: invention relates to formula compound, including its stereochemically isomeric forms, hydrates and solvates, where R1 is selected from hydrogen atom, halogen atom and C1-4-alkoxy; R2 is selected from C1-4-alkyl and C3-6-cycloalkyl; R4 represents C3-7-cycloalkyl; n equals 1; Y is selected from and a equals 4 or 5; R3 and R3' are independently selected from hydrogen atom and C1-6-alkyl. Invention also relates to antiviral pharmaceutical composition based on said formula (I) compound.
EFFECT: obtained are novel compounds and based on them pharmaceutical compositions, which can be applied in medicine in HCV therapy.
12 cl, 3 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
MACROCYCLIC HEPATITIS C VIRUS INIHBITORS | 2006 |
|
RU2437886C2 |
MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | 2006 |
|
RU2441870C2 |
HEPATITIS C VIRUS MACROCYCLIC INHIBITORS | 2006 |
|
RU2486189C2 |
MACROCYCLIC PHENYLCARBAMATES INHIBITING HCV | 2008 |
|
RU2490261C2 |
MACROCYCLIC HEPATITIS C INHIBITORS | 2006 |
|
RU2436787C2 |
PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDES | 2010 |
|
RU2553656C2 |
PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS | 2008 |
|
RU2481340C2 |
BIS-BENZIMIDAZOLE DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2540897C2 |
DIARYL ETHERS | 2010 |
|
RU2528231C2 |
PHENYLETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2538507C2 |
Authors
Dates
2014-06-10—Published
2009-08-14—Filed